EUVIMEDEUVIMED entdecken
Open Access

Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor

Yoshiki Sakai iD, Kavya Adiga iD, Matin Nawabi iD, Sofia Mendez-Lopez iD, Tsai-Ching Hsi iD, David Bilder iD

Science Advances · 2026

DOI: 10.1126/sciadv.aec5131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Yoshiki Sakai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California-Berkeley, Berkeley, CA 94720, USA. Hauptthemen laut MEDLINE: Macrophages, Drosophila Proteins, Neoplasms, Protease Inhibitors. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breaches of epithelial homeostasis trigger an inflammatory response. Not only initiation but also negative regulation of the response is critical, as autoinflammation can cause tissue damage and chronic disease. Epithelial breaches can be signaled by damage-associated molecular patterns (DAMPs), including basement membrane (BM) degradation, that attract inflammatory cells. Here, we show that the conserved glycosylphosphatidylinositol-linked thioester-containing protein Tep3 from Drosophila , the ortholog of human CD109, limits innate immune cell attachment to damaged and transformed epithelia. Tep3 is induced in wounds alongside the matrix metalloprotease 1 (MMP1). Tep3 inhibits MMP1 proteolytic activity, reducing production of a BM DAMP that triggers macrophage association. A Drosophila tumor up-regulates Tep3 to limit an MMP1- and macrophage-dependent antitumor immune response, thus accelerating progression and host death. Hence, fly tumors can exploit a physiological anti-inflammatory axis to pathologically limit their immune restriction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesDrosophila ProteinsNeoplasmsProtease InhibitorsWounds and InjuriesAnimalsMatrix Metalloproteinase 1HumansWound HealingProteolysisDrosophilaDrosophila melanogasterImmunity, Innate

Substanzen

Drosophila ProteinsMatrix Metalloproteinase 1Protease Inhibitors

Autor:innen und Institutionen

  • Department of Molecular and Cell Biology, University of California-Berkeley, Berkeley, CA 94720, USA.

ORCID-Profile: Yoshiki Sakai, Kavya Adiga, Matin Nawabi, Sofia Mendez-Lopez, Tsai-Ching Hsi, David Bilder

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • American Cancer Society
  • Damon Runyon Cancer Research Foundation
  • University of California
  • Mark Foundation

Zitieren

APA

Sakai, Y., Adiga, K., Nawabi, M., Mendez-Lopez, S., Hsi, T. C., & Bilder, D. (2026). Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor. Science Advances. https://doi.org/10.1126/sciadv.aec5131

Vancouver

Sakai Y, Adiga K, Nawabi M, Mendez-Lopez S, Hsi TC, Bilder D. Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor. Science Advances. 2026. doi:10.1126/sciadv.aec5131

BibTeX
@article{Sakai2026,
  author = {Sakai, Yoshiki and Adiga, Kavya and Nawabi, Matin and Mendez-Lopez, Sofia and Hsi, Tsai-Ching and Bilder, David},
  title = {Macrophage restriction in Drosophila wounds and tumors via a matrix degradation–moderating protease inhibitor},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aec5131}
}
Kostenlos starten →